Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience

Anna R. Maurizi, Concetta Suraci, Dario Pitocco, Riccardo Schiaffini, Claudio Tubili, Lelio Morviducci, Renato Giordano, Silvia Manfrini, Davide Lauro, Simona Frontoni, Paolo Pozzilli, Raffaella Buzzetti, D. Bracaglia, D. Bloise, M. Cappa, S. Caputo, M. G. Cavallo, F. Chiaramonte, G. Ciampittiello, E. CicconettiA. Di Flaviani, D. Fava, E. Forte, G. Ghirlanda, A. Giaccari, M. Giuliano, A. Lauria Pantano, F. Leonetti, S. Leotta, M. L. Mancabitti, M. A. Marini, A. Napoli, M. R. Nardone, I. P. Patera, F. Piergiovanni, G. Pugliese, V. Spallone, P. Tatti, F. Tuccinardi, C. Ventura, N. Visalli

Research output: Contribution to journalArticle

Abstract

This document has been developed by a group of Italian diabetologists with extensive experience in continuous subcutaneous insulin infusion (CSII) therapy to provide indications for the clinical management of CSII in diabetic patients (both type 1 and type 2) based on delivery mode operating in Italy. Although the potential benefits of pump therapy in achieving glycemic goals is now accepted, such results cannot be obtained without specific knowledge and skills being conveyed to patients during ad hoc educational training. To ensure that these new technologies reach their full effectiveness, as demonstrated theoretically and clinically, a careful assessment of the overall therapeutic and educational process is required, in both qualitative and quantitative terms. Therefore, to ensure the cost-effectiveness of insulin pump therapy and to justify reimbursement of therapy costs by the National Health System in Italy, in this article we present a model for diabetes and healthcare centers to follow that provides for different levels of expertise in the field of CSII therapy. This model will guarantee the provision of excellent care during insulin pump therapies, thus representing the basis for a successful outcome and expansion of this form of insulin treatment in patients with diabetes while also keeping costs under control.

Original languageEnglish
Pages (from-to)41-44
Number of pages4
JournalJournal of Diabetes
Volume8
Issue number1
DOIs
Publication statusPublished - Jan 1 2016

Keywords

  • Continuous subcutaneous insulin infusion
  • Diabetes management
  • Insulin pump therapy
  • Multidisciplinary insulin pump team

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience'. Together they form a unique fingerprint.

  • Cite this

    Maurizi, A. R., Suraci, C., Pitocco, D., Schiaffini, R., Tubili, C., Morviducci, L., Giordano, R., Manfrini, S., Lauro, D., Frontoni, S., Pozzilli, P., Buzzetti, R., Bracaglia, D., Bloise, D., Cappa, M., Caputo, S., Cavallo, M. G., Chiaramonte, F., Ciampittiello, G., ... Visalli, N. (2016). Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience. Journal of Diabetes, 8(1), 41-44. https://doi.org/10.1111/1753-0407.12321